HEADER TRANSFERASE 03-APR-20 6WFK
TITLE CRYSTAL STRUCTURE OF HUMAN NAA50 IN COMPLEX WITH COA AND AN INHIBITOR
TITLE 2 (COMPOUND 4A) IDENTIFIED USING DNA ENCODED LIBRARY TECHNOLOGY
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: N-ALPHA-ACETYLTRANSFERASE 50;
COMPND 3 CHAIN: A, B, C;
COMPND 4 SYNONYM: HNAA50P,N-ACETYLTRANSFERASE 13,N-ACETYLTRANSFERASE 5,HNAT5,
COMPND 5 N-ACETYLTRANSFERASE SAN HOMOLOG,HSAN,N-EPSILON-ACETYLTRANSFERASE 50,
COMPND 6 NATE CATALYTIC SUBUNIT, NAA50;
COMPND 7 EC: 2.3.1.258,2.3.1.-;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: NAA50, MAK3, NAT13, NAT5;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008
KEYWDS N-ALPHA-ACETYLTRANSFERASE 50, INHIBITOR COMPLEX, DNA ENCODED LIBRARY,
KEYWDS 2 COA, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR S.E.GREASLEY,J.FENG,Y.-L.DENG,A.E.STEWART
REVDAT 2 18-OCT-23 6WFK 1 REMARK
REVDAT 1 01-JUL-20 6WFK 0
JRNL AUTH P.P.KUNG,P.BINGHAM,B.J.BURKE,Q.CHEN,X.CHENG,Y.L.DENG,D.DOU,
JRNL AUTH 2 J.FENG,G.M.GALLEGO,M.R.GEHRING,S.K.GRANT,S.GREASLEY,
JRNL AUTH 3 A.R.HARRIS,K.A.MAEGLEY,J.MEIER,X.MENG,J.L.MONTANO,
JRNL AUTH 4 B.A.MORGAN,B.S.NAUGHTON,P.B.PALDE,T.A.PAUL,P.RICHARDSON,
JRNL AUTH 5 S.SAKATA,A.SHAGINIAN,W.K.SONNENBURG,C.SUBRAMANYAM,
JRNL AUTH 6 S.TIMOFEEVSKI,J.WAN,W.YAN,A.E.STEWART
JRNL TITL CHARACTERIZATION OF SPECIFICN-ALPHA-ACETYLTRANSFERASE 50
JRNL TITL 2 (NAA50) INHIBITORS IDENTIFIED USING A DNA ENCODED LIBRARY.
JRNL REF ACS MED.CHEM.LETT. V. 11 1175 2020
JRNL REFN ISSN 1948-5875
JRNL PMID 32550998
JRNL DOI 10.1021/ACSMEDCHEMLETT.0C00029
REMARK 2
REMARK 2 RESOLUTION. 1.87 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.7
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 64.63
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 73.5
REMARK 3 NUMBER OF REFLECTIONS : 38205
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.201
REMARK 3 R VALUE (WORKING SET) : 0.200
REMARK 3 FREE R VALUE : 0.222
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.850
REMARK 3 FREE R VALUE TEST SET COUNT : 1853
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.98
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL
REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 731
REMARK 3 BIN R VALUE (WORKING SET) : 0.2190
REMARK 3 BIN FREE R VALUE : 0.2376
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.44
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 34
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3698
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 261
REMARK 3 SOLVENT ATOMS : 261
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 43.19
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.48
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.51760
REMARK 3 B22 (A**2) : 0.49290
REMARK 3 B33 (A**2) : 0.02470
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.02010
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.270
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.185
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.152
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.185
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.152
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 4118 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 5649 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1441 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES : 717 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 4118 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 508 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 4750 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.17
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.22
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.05
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6WFK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-APR-20.
REMARK 100 THE DEPOSITION ID IS D_1000248129.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 14-NOV-18
REMARK 200 TEMPERATURE (KELVIN) : 93
REMARK 200 PH : 5.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AUTOPROC
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38205
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.870
REMARK 200 RESOLUTION RANGE LOW (A) : 64.630
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 91.3
REMARK 200 DATA REDUNDANCY : 3.300
REMARK 200 R MERGE (I) : 0.05400
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.87
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03
REMARK 200 COMPLETENESS FOR SHELL (%) : 55.5
REMARK 200 DATA REDUNDANCY IN SHELL : 2.50
REMARK 200 R MERGE FOR SHELL (I) : 0.77800
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.200
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: BUSTER
REMARK 200 STARTING MODEL: UNPUBLISHED MODEL, SOLVED USING PDB ENTRY 2OB0
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 54.85
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.72
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: COMPOUND 4A SOAKED INTO CRYSTALS OF
REMARK 280 NAA50+COA. COA CO-CRYSTALS: NAA50 APO PROTEIN (14.3 MG/ML) WAS
REMARK 280 INCUBATED WITH COA IN A 1:3 MOLAR RATIO ON ICE FOR 60 MIN.
REMARK 280 CRYSTALLIZATION SOLUTION: 0.1 M NA ACETATE, PH5.0, 25% (W/V) PEG
REMARK 280 3350, 10 MM DITHIOTHREITOL (DTT), AND 0.1% DIOXANE, VAPOR
REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 294K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 51.19000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2, 3
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 3
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A -1
REMARK 465 SER A 0
REMARK 465 MET A 1
REMARK 465 LYS A 155
REMARK 465 VAL A 156
REMARK 465 PRO A 157
REMARK 465 SER A 158
REMARK 465 GLY A 159
REMARK 465 GLN A 160
REMARK 465 ASN A 161
REMARK 465 ALA A 162
REMARK 465 ASP A 163
REMARK 465 VAL A 164
REMARK 465 GLN A 165
REMARK 465 LYS A 166
REMARK 465 THR A 167
REMARK 465 ASP A 168
REMARK 465 ASN A 169
REMARK 465 GLY B -1
REMARK 465 SER B 0
REMARK 465 MET B 1
REMARK 465 LYS B 2
REMARK 465 LYS B 155
REMARK 465 VAL B 156
REMARK 465 PRO B 157
REMARK 465 SER B 158
REMARK 465 GLY B 159
REMARK 465 GLN B 160
REMARK 465 ASN B 161
REMARK 465 ALA B 162
REMARK 465 ASP B 163
REMARK 465 VAL B 164
REMARK 465 GLN B 165
REMARK 465 LYS B 166
REMARK 465 THR B 167
REMARK 465 ASP B 168
REMARK 465 ASN B 169
REMARK 465 GLY C -1
REMARK 465 SER C 0
REMARK 465 MET C 1
REMARK 465 LYS C 2
REMARK 465 GLY C 3
REMARK 465 LYS C 155
REMARK 465 VAL C 156
REMARK 465 PRO C 157
REMARK 465 SER C 158
REMARK 465 GLY C 159
REMARK 465 GLN C 160
REMARK 465 ASN C 161
REMARK 465 ALA C 162
REMARK 465 ASP C 163
REMARK 465 VAL C 164
REMARK 465 GLN C 165
REMARK 465 LYS C 166
REMARK 465 THR C 167
REMARK 465 ASP C 168
REMARK 465 ASN C 169
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ARG A 141 CZ NH1 NH2
REMARK 470 ARG B 141 CG CD NE CZ NH1 NH2
REMARK 470 ARG C 141 CG CD NE CZ NH1 NH2
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue COA A 201
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue U2J A 202
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue COA B 201
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue U2J B 202
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue COA C 201
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue U2J C 202
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 6WF3 RELATED DB: PDB
REMARK 900 RELATED ID: 6WF5 RELATED DB: PDB
REMARK 900 RELATED ID: 6WFG RELATED DB: PDB
REMARK 900 DEL HIT
DBREF 6WFK A 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169
DBREF 6WFK B 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169
DBREF 6WFK C 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169
SEQADV 6WFK GLY A -1 UNP Q9GZZ1 EXPRESSION TAG
SEQADV 6WFK SER A 0 UNP Q9GZZ1 EXPRESSION TAG
SEQADV 6WFK GLY B -1 UNP Q9GZZ1 EXPRESSION TAG
SEQADV 6WFK SER B 0 UNP Q9GZZ1 EXPRESSION TAG
SEQADV 6WFK GLY C -1 UNP Q9GZZ1 EXPRESSION TAG
SEQADV 6WFK SER C 0 UNP Q9GZZ1 EXPRESSION TAG
SEQRES 1 A 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL
SEQRES 2 A 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN
SEQRES 3 A 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS
SEQRES 4 A 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR
SEQRES 5 A 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL
SEQRES 6 A 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR
SEQRES 7 A 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY
SEQRES 8 A 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS
SEQRES 9 A 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE
SEQRES 10 A 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY
SEQRES 11 A 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG
SEQRES 12 A 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU
SEQRES 13 A 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR
SEQRES 14 A 171 ASP ASN
SEQRES 1 B 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL
SEQRES 2 B 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN
SEQRES 3 B 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS
SEQRES 4 B 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR
SEQRES 5 B 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL
SEQRES 6 B 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR
SEQRES 7 B 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY
SEQRES 8 B 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS
SEQRES 9 B 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE
SEQRES 10 B 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY
SEQRES 11 B 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG
SEQRES 12 B 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU
SEQRES 13 B 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR
SEQRES 14 B 171 ASP ASN
SEQRES 1 C 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL
SEQRES 2 C 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN
SEQRES 3 C 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS
SEQRES 4 C 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR
SEQRES 5 C 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL
SEQRES 6 C 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR
SEQRES 7 C 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY
SEQRES 8 C 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS
SEQRES 9 C 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE
SEQRES 10 C 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY
SEQRES 11 C 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG
SEQRES 12 C 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU
SEQRES 13 C 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR
SEQRES 14 C 171 ASP ASN
HET COA A 201 48
HET U2J A 202 62
HET COA B 201 48
HET U2J B 202 62
HET COA C 201 48
HET U2J C 202 62
HETNAM COA COENZYME A
HETNAM U2J (4S)-1-METHYL-N-{(3S,5S)-5-[4-(METHYLCARBAMOYL)-1,3-
HETNAM 2 U2J THIAZOL-2-YL]-1-[4-(1H-TETRAZOL-5-YL)BENZENE-1-
HETNAM 3 U2J CARBONYL]PYRROLIDIN-3-YL}-2,6-
HETNAM 4 U2J DIOXOHEXAHYDROPYRIMIDINE-4-CARBOXAMIDE
FORMUL 4 COA 3(C21 H36 N7 O16 P3 S)
FORMUL 5 U2J 3(C23 H24 N10 O5 S)
FORMUL 10 HOH *261(H2 O)
HELIX 1 AA1 ASN A 15 PHE A 27 1 13
HELIX 2 AA2 ASN A 32 LEU A 40 1 9
HELIX 3 AA3 GLU A 41 GLU A 44 5 4
HELIX 4 AA4 ALA A 81 ARG A 84 5 4
HELIX 5 AA5 GLY A 87 GLY A 104 1 18
HELIX 6 AA6 ASN A 117 PHE A 127 1 11
HELIX 7 AA7 ASN B 15 PHE B 27 1 13
HELIX 8 AA8 ASN B 32 LEU B 40 1 9
HELIX 9 AA9 GLU B 41 GLU B 44 5 4
HELIX 10 AB1 ALA B 81 ARG B 84 5 4
HELIX 11 AB2 GLY B 87 GLY B 104 1 18
HELIX 12 AB3 ASN B 117 PHE B 127 1 11
HELIX 13 AB4 ASN C 15 PHE C 27 1 13
HELIX 14 AB5 ASN C 32 LEU C 40 1 9
HELIX 15 AB6 GLU C 41 GLU C 44 5 4
HELIX 16 AB7 ALA C 81 ARG C 84 5 4
HELIX 17 AB8 GLY C 87 GLY C 104 1 18
HELIX 18 AB9 ASN C 117 PHE C 127 1 11
SHEET 1 AA1 7 ILE A 6 ASP A 10 0
SHEET 2 AA1 7 ALA A 46 PHE A 51 -1 O TYR A 50 N GLU A 7
SHEET 3 AA1 7 ILE A 54 SER A 66 -1 O GLY A 57 N ALA A 49
SHEET 4 AA1 7 GLN A 69 CYS A 79 -1 O ARG A 71 N ASP A 64
SHEET 5 AA1 7 ASN A 108 GLN A 114 1 O TYR A 110 N LEU A 72
SHEET 6 AA1 7 ALA A 147 ASN A 153 -1 O HIS A 148 N VAL A 113
SHEET 7 AA1 7 GLU A 130 LYS A 135 -1 N LYS A 135 O ALA A 147
SHEET 1 AA2 7 ILE B 6 ASP B 10 0
SHEET 2 AA2 7 ALA B 46 PHE B 51 -1 O LEU B 48 N GLY B 9
SHEET 3 AA2 7 ILE B 54 SER B 66 -1 O GLY B 57 N ALA B 49
SHEET 4 AA2 7 GLN B 69 CYS B 79 -1 O ARG B 71 N ASP B 64
SHEET 5 AA2 7 ASN B 108 GLN B 114 1 O ASN B 108 N LEU B 72
SHEET 6 AA2 7 ALA B 147 ASN B 153 -1 O HIS B 148 N VAL B 113
SHEET 7 AA2 7 GLU B 130 LYS B 135 -1 N GLU B 133 O VAL B 149
SHEET 1 AA3 7 ILE C 6 ASP C 10 0
SHEET 2 AA3 7 ALA C 46 PHE C 51 -1 O LEU C 48 N GLY C 9
SHEET 3 AA3 7 ILE C 54 SER C 66 -1 O GLY C 57 N ALA C 49
SHEET 4 AA3 7 GLN C 69 CYS C 79 -1 O ARG C 71 N ASP C 64
SHEET 5 AA3 7 ASN C 108 GLN C 114 1 O TYR C 110 N ILE C 74
SHEET 6 AA3 7 ALA C 147 ASN C 153 -1 O HIS C 148 N VAL C 113
SHEET 7 AA3 7 GLU C 130 LYS C 135 -1 N LYS C 135 O ALA C 147
CISPEP 1 GLU A 143 PRO A 144 0 -4.11
CISPEP 2 GLU B 143 PRO B 144 0 -5.10
CISPEP 3 GLU C 143 PRO C 144 0 -4.07
SITE 1 AC1 23 PHE A 27 LEU A 77 GLY A 78 CYS A 79
SITE 2 AC1 23 ARG A 84 ARG A 85 LEU A 86 GLY A 87
SITE 3 AC1 23 ILE A 88 GLY A 89 THR A 90 LEU A 111
SITE 4 AC1 23 ASN A 117 SER A 119 ASP A 122 PHE A 123
SITE 5 AC1 23 LYS A 126 U2J A 202 HOH A 301 HOH A 302
SITE 6 AC1 23 HOH A 303 HOH A 326 HOH A 366
SITE 1 AC2 16 PHE A 27 VAL A 29 TYR A 31 ARG A 62
SITE 2 AC2 16 TYR A 73 MET A 75 HIS A 112 VAL A 113
SITE 3 AC2 16 GLN A 114 TYR A 138 TYR A 139 LYS A 140
SITE 4 AC2 16 ARG A 141 COA A 201 HOH A 332 HOH A 341
SITE 1 AC3 21 PHE B 27 LEU B 77 GLY B 78 CYS B 79
SITE 2 AC3 21 ARG B 84 ARG B 85 LEU B 86 GLY B 87
SITE 3 AC3 21 ILE B 88 GLY B 89 THR B 90 ASN B 117
SITE 4 AC3 21 SER B 119 ASP B 122 PHE B 123 LYS B 126
SITE 5 AC3 21 U2J B 202 HOH B 302 HOH B 314 HOH B 315
SITE 6 AC3 21 HOH B 348
SITE 1 AC4 15 PHE B 27 PRO B 28 VAL B 29 TYR B 31
SITE 2 AC4 15 ARG B 62 TYR B 73 MET B 75 HIS B 112
SITE 3 AC4 15 VAL B 113 GLN B 114 TYR B 138 TYR B 139
SITE 4 AC4 15 LYS B 140 ARG B 141 COA B 201
SITE 1 AC5 21 PHE C 27 LEU C 77 GLY C 78 CYS C 79
SITE 2 AC5 21 ARG C 84 ARG C 85 LEU C 86 GLY C 87
SITE 3 AC5 21 ILE C 88 GLY C 89 THR C 90 ASN C 117
SITE 4 AC5 21 SER C 119 ASP C 122 PHE C 123 LYS C 126
SITE 5 AC5 21 HOH C 301 HOH C 303 HOH C 304 HOH C 306
SITE 6 AC5 21 HOH C 308
SITE 1 AC6 16 PHE C 27 PRO C 28 VAL C 29 TYR C 31
SITE 2 AC6 16 ARG C 62 TYR C 73 MET C 75 HIS C 112
SITE 3 AC6 16 VAL C 113 GLN C 114 TYR C 138 TYR C 139
SITE 4 AC6 16 LYS C 140 ARG C 141 HOH C 302 HOH C 314
CRYST1 48.350 102.380 67.550 90.00 106.92 90.00 P 1 21 1 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.020683 0.000000 0.006292 0.00000
SCALE2 0.000000 0.009768 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015474 0.00000